Hematuria, or blood in the urine, can be an early sign of lower urinary tract diseases (LUTD)1, including Feline Idiopathic Cystitis (FIC), which is one of the most common LUTDs in cats.
The product comes in small pouches containing white granules which are sprinkled over clean cat litter and turn blue if there is any trace of blood in the urine. Hematuria Detection aims to provide owners with “clear and reliable” results within seconds – revealing the first warning signs of potential LUTD. Owners are advised to immediately contact their veterinarian if the granules change color or if their cat shows any signs of illness or abnormal behavior.
Hematuria Detection will be available through veterinarians as a follow-up tool for owners of cats with a history of FLUTD.
Up to 50% of cats that experience an episode of lower urinary tract disease can have a recurrence within a year. As cats tend to hide their symptoms, owners are often unaware of their cat’s health issues until long after they develop, which can delay treatment.
Hematuria Detection is supported by clinically-proven results. An internal study by Royal Canin revealed over 99% of cats accepted the granules on their litter and 90% of pet owners were satisfied with the effectiveness of the tool.
This is Royal Canin’s first launch of a non-nutritional product, and is the result of a collaboration with Blücare Laboratories, a company that specialises in early detection tools for cats and dogs.
Yannick Soulard, new business development director at Royal Canin, said: “We are incredibly proud to be launching our very first early detection tool worldwide. We’re certain Hematuria Detection will complement the great work of veterinarians while encouraging cat owners to recognise early signs of potential urinary conditions.
“We are excited to be pioneering another product category that will allow us to continue pursuing our purpose of making a better world for pets.”